Screener
Indivior Pharmaceuticals, Inc. INDV Inventories
Inventories at other companies
Other financials
Where this comes from
Reported directly by Indivior Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:InventoryNoncurrent.
The source filing: Indivior Pharmaceuticals, Inc.’s 10-Q, filed April 30, 2026.
- Filed
- Apr 30, 2026, 4:02 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001628280-26-028850
Inventory expected to be sold more than one year from the balance sheet date is classified as noncurrent inventory and recorded in other noncurrent assets on the condensed consolidated balance sheets. At March 31, 2026 and December 31, 2025, the noncurrent portion of inventory was $1 million and $2 million, respectively, and consisted primarily of raw materials and consumables.
Item 1. Unaudited Condensed Financial Statements.
FAQ
- What is Indivior Pharmaceuticals, Inc.'s inventories?
- Indivior Pharmaceuticals, Inc. (INDV) reported inventories of $1M in Q1 2026.
- How has Indivior Pharmaceuticals, Inc.'s inventories changed year-over-year?
- Indivior Pharmaceuticals, Inc.'s inventories decreased by 91.7% year-over-year, from $12M to $1M.
- What is the long-term trend for Indivior Pharmaceuticals, Inc.'s inventories?
- Over 3 years (2022 to 2025), Indivior Pharmaceuticals, Inc.'s inventories has grown at a 2.2% compound annual growth rate (CAGR), from $30M to $32M.
- What does inventories mean?
- Total inventory including raw materials, work-in-progress, and finished goods, valued at the lower of cost or net realizable value.
Ask your AI about Indivior Pharmaceuticals, Inc.'s inventories.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude